EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications

Pranav Kumar Prabhakar iD, Navneet Khurana iD, Manish Vyas, Vikas Sharma, Gaber El-Saber Batiha iD, Harpreet Kaur, Jashanpreet Singh, Deepak Kumar iD, Neha Sharma, Ajeet Kaushik iD, Raj Kumar iD

Pharmaceutics · 30.01.2023 · 15 (2) · 451

DOI: 10.3390/pharmaceutics15020451 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 30.01.2023. Verfasst von Pranav Kumar Prabhakar und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Allied Medical Sciences, Lovely Professional University, Punjab 144411, India. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus, a causative agent of the common cold to a much more complicated disease such as “severe acute respiratory syndrome (SARS-CoV-2), Middle East Respiratory Syndrome (MERS-CoV-2), and Coronavirus Disease 2019 (COVID-19)”, is a member of the coronaviridae family and contains a positive-sense single-stranded RNA of 26–32 kilobase pairs. COVID-19 has shown very high mortality and morbidity and imparted a significantly impacted socioeconomic status. There are many variants of SARS-CoV-2 that have originated from the mutation of the genetic material of the original coronavirus. This has raised the demand for efficient treatment/therapy to manage newly emerged SARS-CoV-2 infections successfully. However, different types of vaccines have been developed and administered to patients but need more attention because COVID-19 is not under complete control. In this article, currently developed nanotechnology-based vaccines are explored, such as inactivated virus vaccines, mRNA-based vaccines, DNA-based vaccines, S-protein-based vaccines, virus-vectored vaccines, etc. One of the important aspects of vaccines is their administration inside the host body wherein nanotechnology can play a very crucial role. Currently, more than 26 nanotechnology-based COVID-19 vaccine candidates are in various phases of clinical trials. Nanotechnology is one of the growing fields in drug discovery and drug delivery that can also be used for the tackling of coronavirus. Nanotechnology can be used in various ways to design and develop tools and strategies for detection, diagnosis, and therapeutic and vaccine development to protect against COVID-19. The design of instruments for speedy, precise, and sensitive diagnosis, the fabrication of potent sanitizers, the delivery of extracellular antigenic components or mRNA-based vaccines into human tissues, and the administration of antiretroviral medicines into the organism are nanotechnology-based strategies for COVID-19 management. Herein, we discuss the application of nanotechnology in COVID-19 vaccine development and the challenges and opportunities in this approach.

Schlagwörter

Stichwörter der Autor:innen

COVID-19diagnosismRNAmutationnanotechnologyvaccinevirus-vectored

Autor:innen und Institutionen

  • School of Allied Medical Sciences, Lovely Professional University, Punjab 144411, India.
  • School of Pharmaceutical Sciences, Lovely Professional University, Punjab 144411, India.
  • Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt.
  • School of Chemical Engineering and Physical Sciences, Lovely Professional University, Punjab 144411, India.
  • NanoBioTech Laboratory, Department of Environmental Engineering, Florida Polytechnic University, Lakeland, FL 33805, USA.
  • School of Engineering, University of Petroleum and Energy Studies (UPES), Uttarakhand 248007, India.

ORCID-Profile: Pranav Kumar Prabhakar, Navneet Khurana, Gaber El-Saber Batiha, Deepak Kumar, Ajeet Kaushik, Raj Kumar

Zitieren

APA

Prabhakar, P. K., Khurana, N., Vyas, M., Sharma, V., Batiha, G. E., Kaur, H., Singh, J., Kumar, D., Sharma, N., Kaushik, A., & Kumar, R. (2023). Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications. Pharmaceutics, 15(2), 451. https://doi.org/10.3390/pharmaceutics15020451

Vancouver

Prabhakar PK, Khurana N, Vyas M, Sharma V, Batiha GE, Kaur H, et al. Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications. Pharmaceutics. 2023;15(2):451. doi:10.3390/pharmaceutics15020451

BibTeX
@article{Prabhakar2023,
  author = {Prabhakar, Pranav Kumar and Khurana, Navneet and Vyas, Manish and Sharma, Vikas and Batiha, Gaber El-Saber and Kaur, Harpreet and Singh, Jashanpreet and Kumar, Deepak and Sharma, Neha and Kaushik, Ajeet and Kumar, Raj},
  title = {Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {451},
  doi = {10.3390/pharmaceutics15020451}
}
Kostenlos starten →